Back

Can we predict the effect of antiarrhythmic pharmacotherapy in atrial fibrillation and metabolic syndrome patients: focus on galectin-3

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Assistant Professor Valery Ionin

Saint Petersburg First Pavlov State Medical University, Saint Petersburg (Russian Federation)

28 More presentations in this session

Presentation thumbnail
Increased arrhythmia stability is associated with risk-factor specific structural remodelling in a porcine model of arterial hypertension and atrial fibrillation
Doctor M. Manninger (Graz, AT)
Abstract Slides
Presentation thumbnail
Inhibition of small conductance Ca2+-activated K+-Channels converts and prevents reinduction of atrial fibrillation in pigs where vernakalant fails
Doctor J. Diness (Frederiksberg, DK)
Abstract
Presentation thumbnail
Inducibility of atrial fibrillation after epicardial injection of the new pharmaceutical composition containing botulinum toxin into epicardial fat pads
Doctor A. Romanov (Novosibirsk, RU)
Abstract
Presentation thumbnail
Glucagon-like-peptide-1 (GLP-1) Suppresses the Induction of Atrial Fibrillation in Canine Model of Atrial Fibrillation.
Doctor H. Nakamura (Sagamihara, JP)
Abstract Slides
Presentation thumbnail
Plasma levels of miRNAs regulating apelin expression in patients with atrial fibrillation
Professor C. Falcone (Pavia, IT)

Access the full session

Session thumbnail
Poster session 5 - Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources